Annual Revenue
$90.12 M
-$1.93 M-2.10%
31 December 2023
Summary:
Nektar Therapeutics annual revenue is currently $90.12 million, with the most recent change of -$1.93 million (-2.10%) on 31 December 2023. During the last 3 years, it has fallen by -$62.79 million (-41.06%). NKTR annual revenue is now -92.45% below its all-time high of $1.19 billion, reached on 31 December 2018.NKTR Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$24.12 M
+$635.00 K+2.70%
30 September 2024
Summary:
Nektar Therapeutics quarterly revenue is currently $24.12 million, with the most recent change of +$635.00 thousand (+2.70%) on 30 September 2024. Over the past year, it has dropped by -$20.00 thousand (-0.08%). NKTR quarterly revenue is now -97.78% below its all-time high of $1.09 billion, reached on 30 June 2018.NKTR Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$93.14 M
-$20.00 K-0.02%
30 September 2024
Summary:
Nektar Therapeutics TTM revenue is currently $93.14 million, with the most recent change of -$20.00 thousand (-0.02%) on 30 September 2024. Over the past year, it has increased by +$4.88 million (+5.53%). NKTR TTM revenue is now -93.22% below its all-time high of $1.37 billion, reached on 30 June 2018.NKTR TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NKTR Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.1% | -0.1% | +5.5% |
| 3 y3 years | -41.1% | -3.2% | -7.2% |
| 5 y5 years | -92.5% | -17.4% | -22.8% |
NKTR Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -41.1% | at low | -3.5% | +17.7% | -9.7% | +6.2% |
| 5 y | 5 years | -92.5% | at low | -52.3% | +17.7% | -43.0% | +6.2% |
| alltime | all time | -92.5% | +5201.3% | -97.8% | +7941.3% | -93.2% | >+9999.0% |
Nektar Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $24.12 M(+2.7%) | $93.14 M(-0.0%) |
| June 2024 | - | $23.49 M(+8.5%) | $93.16 M(+3.3%) |
| Mar 2024 | - | $21.64 M(-9.4%) | $90.17 M(+0.0%) |
| Dec 2023 | $90.12 M(-2.1%) | $23.89 M(-1.1%) | $90.12 M(+2.1%) |
| Sept 2023 | - | $24.14 M(+17.8%) | $88.26 M(+0.6%) |
| June 2023 | - | $20.50 M(-5.1%) | $87.74 M(-1.2%) |
| Mar 2023 | - | $21.59 M(-1.9%) | $88.83 M(-3.5%) |
| Dec 2022 | $92.06 M(-9.7%) | $22.02 M(-6.8%) | $92.06 M(-3.1%) |
| Sept 2022 | - | $23.63 M(+9.5%) | $95.04 M(-1.3%) |
| June 2022 | - | $21.59 M(-13.0%) | $96.34 M(-6.5%) |
| Mar 2022 | - | $24.82 M(-0.7%) | $103.08 M(+1.2%) |
| Dec 2021 | $101.91 M(-33.4%) | $25.01 M(+0.4%) | $101.91 M(+1.5%) |
| Sept 2021 | - | $24.92 M(-12.0%) | $100.36 M(-4.8%) |
| June 2021 | - | $28.33 M(+19.8%) | $105.47 M(-16.3%) |
| Mar 2021 | - | $23.65 M(+0.8%) | $125.99 M(-17.6%) |
| Dec 2020 | $152.91 M(+33.4%) | $23.46 M(-21.9%) | $152.91 M(-6.4%) |
| Sept 2020 | - | $30.03 M(-38.5%) | $163.31 M(+0.5%) |
| June 2020 | - | $48.85 M(-3.4%) | $162.50 M(+18.6%) |
| Mar 2020 | - | $50.57 M(+49.4%) | $136.97 M(+19.5%) |
| Dec 2019 | $114.62 M(-90.4%) | $33.86 M(+15.9%) | $114.62 M(-4.9%) |
| Sept 2019 | - | $29.22 M(+25.3%) | $120.58 M(+1.2%) |
| June 2019 | - | $23.32 M(-17.4%) | $119.13 M(-89.9%) |
| Mar 2019 | - | $28.22 M(-29.1%) | $1.18 B(-0.8%) |
| Dec 2018 | $1.19 B(+287.8%) | $39.83 M(+43.5%) | $1.19 B(-4.5%) |
| Sept 2018 | - | $27.76 M(-97.4%) | $1.25 B(-9.1%) |
| June 2018 | - | $1.09 B(+2761.1%) | $1.37 B(+328.1%) |
| Mar 2018 | - | $38.02 M(-60.2%) | $321.00 M(+4.3%) |
| Dec 2017 | $307.71 M(+86.0%) | $95.47 M(-37.6%) | $307.71 M(+23.2%) |
| Sept 2017 | - | $152.93 M(+342.1%) | $249.70 M(+87.6%) |
| June 2017 | - | $34.59 M(+39.9%) | $133.10 M(+1.4%) |
| Mar 2017 | - | $24.73 M(-34.0%) | $131.28 M(-20.6%) |
| Dec 2016 | $165.44 M(-28.3%) | $37.45 M(+3.1%) | $165.44 M(-1.1%) |
| Sept 2016 | - | $36.34 M(+10.9%) | $167.36 M(-12.4%) |
| June 2016 | - | $32.77 M(-44.3%) | $190.97 M(+5.6%) |
| Mar 2016 | - | $58.88 M(+49.6%) | $180.87 M(-21.6%) |
| Dec 2015 | $230.78 M(+15.0%) | $39.37 M(-34.3%) | $230.78 M(+9.4%) |
| Sept 2015 | - | $59.95 M(+164.6%) | $210.97 M(-25.7%) |
| June 2015 | - | $22.66 M(-79.2%) | $283.88 M(-2.0%) |
| Mar 2015 | - | $108.80 M(+456.5%) | $289.74 M(+44.4%) |
| Dec 2014 | $200.71 M(+34.8%) | $19.55 M(-85.3%) | $200.71 M(-5.5%) |
| Sept 2014 | - | $132.87 M(+366.0%) | $212.30 M(+51.3%) |
| June 2014 | - | $28.51 M(+44.2%) | $140.34 M(-3.7%) |
| Mar 2014 | - | $19.77 M(-36.5%) | $145.69 M(-2.2%) |
| Dec 2013 | $148.92 M(+83.4%) | $31.15 M(-48.9%) | $148.92 M(+7.2%) |
| Sept 2013 | - | $60.91 M(+79.9%) | $138.92 M(+44.1%) |
| June 2013 | - | $33.86 M(+47.2%) | $96.42 M(+11.8%) |
| Mar 2013 | - | $23.00 M(+8.8%) | $86.25 M(+6.2%) |
| Dec 2012 | $81.19 M(+13.6%) | $21.15 M(+14.8%) | $81.19 M(+7.1%) |
| Sept 2012 | - | $18.41 M(-22.3%) | $75.83 M(-10.2%) |
| June 2012 | - | $23.68 M(+32.0%) | $84.48 M(+8.1%) |
| Mar 2012 | - | $17.95 M(+13.7%) | $78.13 M(+9.3%) |
| Dec 2011 | $71.48 M(-55.1%) | $15.78 M(-41.7%) | $71.48 M(-29.2%) |
| Sept 2011 | - | $27.07 M(+56.2%) | $101.01 M(-9.7%) |
| June 2011 | - | $17.33 M(+53.4%) | $111.87 M(-18.4%) |
| Mar 2011 | - | $11.30 M(-75.1%) | $137.10 M(-13.8%) |
| Dec 2010 | $159.04 M(+121.1%) | $45.31 M(+19.5%) | $159.04 M(+4.1%) |
| Sept 2010 | - | $37.92 M(-10.9%) | $152.73 M(+22.2%) |
| June 2010 | - | $42.56 M(+28.1%) | $125.03 M(+31.0%) |
| Mar 2010 | - | $33.24 M(-14.8%) | $95.46 M(+32.7%) |
| Dec 2009 | $71.93 M | $39.01 M(+281.6%) | $71.93 M(+17.4%) |
| Sept 2009 | - | $10.22 M(-21.3%) | $61.27 M(-15.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2009 | - | $12.99 M(+33.7%) | $72.49 M(-9.3%) |
| Mar 2009 | - | $9.71 M(-65.7%) | $79.90 M(-11.4%) |
| Dec 2008 | $90.19 M(-67.0%) | $28.35 M(+32.2%) | $90.19 M(-29.3%) |
| Sept 2008 | - | $21.44 M(+5.1%) | $127.61 M(-21.5%) |
| June 2008 | - | $20.40 M(+2.0%) | $162.49 M(-21.9%) |
| Mar 2008 | - | $19.99 M(-69.6%) | $208.00 M(-23.8%) |
| Dec 2007 | $273.03 M(+25.4%) | $65.77 M(+16.8%) | $273.03 M(-1.5%) |
| Sept 2007 | - | $56.32 M(-14.6%) | $277.16 M(-0.8%) |
| June 2007 | - | $65.92 M(-22.5%) | $279.47 M(+2.1%) |
| Mar 2007 | - | $85.02 M(+21.6%) | $273.77 M(+25.7%) |
| Dec 2006 | $217.72 M(+72.4%) | $69.90 M(+19.2%) | $217.72 M(+20.5%) |
| Sept 2006 | - | $58.63 M(-2.6%) | $180.69 M(+14.1%) |
| June 2006 | - | $60.22 M(+108.0%) | $158.42 M(+25.0%) |
| Mar 2006 | - | $28.96 M(-11.9%) | $126.74 M(+0.4%) |
| Dec 2005 | $126.28 M(+10.5%) | $32.88 M(-9.6%) | $126.28 M(+1.2%) |
| Sept 2005 | - | $36.35 M(+27.3%) | $124.76 M(+6.7%) |
| June 2005 | - | $28.55 M(+0.2%) | $116.96 M(+0.0%) |
| Mar 2005 | - | $28.49 M(-9.2%) | $116.93 M(+2.3%) |
| Dec 2004 | $114.27 M(+7.5%) | $31.37 M(+9.9%) | $114.27 M(+5.3%) |
| Sept 2004 | - | $28.55 M(+0.1%) | $108.53 M(+1.1%) |
| June 2004 | - | $28.53 M(+10.4%) | $107.34 M(+0.7%) |
| Mar 2004 | - | $25.83 M(+0.8%) | $106.56 M(+0.3%) |
| Dec 2003 | $106.26 M(+12.0%) | $25.62 M(-6.3%) | $106.26 M(+2.9%) |
| Sept 2003 | - | $27.36 M(-1.4%) | $103.26 M(+4.2%) |
| June 2003 | - | $27.75 M(+8.7%) | $99.12 M(+5.9%) |
| Mar 2003 | - | $25.53 M(+12.8%) | $93.63 M(-1.3%) |
| Dec 2002 | $94.84 M(+22.4%) | $22.63 M(-2.5%) | $94.84 M(-1.6%) |
| Sept 2002 | - | $23.22 M(+4.3%) | $96.38 M(+0.9%) |
| June 2002 | - | $22.25 M(-16.8%) | $95.57 M(+6.0%) |
| Mar 2002 | - | $26.75 M(+10.7%) | $90.12 M(+16.3%) |
| Dec 2001 | $77.47 M(+50.0%) | $24.17 M(+7.9%) | $77.47 M(+16.6%) |
| Sept 2001 | - | $22.41 M(+33.4%) | $66.45 M(+14.4%) |
| June 2001 | - | $16.80 M(+19.2%) | $58.10 M(+5.5%) |
| Mar 2001 | - | $14.10 M(+7.2%) | $55.09 M(+6.7%) |
| Dec 2000 | $51.63 M(+24.8%) | $13.15 M(-6.5%) | $51.63 M(+0.1%) |
| Sept 2000 | - | $14.06 M(+2.0%) | $51.56 M(+7.1%) |
| June 2000 | - | $13.79 M(+29.7%) | $48.12 M(+8.8%) |
| Mar 2000 | - | $10.63 M(-18.7%) | $44.23 M(+6.9%) |
| Dec 1999 | $41.36 M(+89.8%) | $13.07 M(+23.0%) | $41.38 M(+19.2%) |
| Sept 1999 | - | $10.63 M(+7.4%) | $34.70 M(+19.8%) |
| June 1999 | - | $9.90 M(+27.2%) | $28.98 M(+12.5%) |
| Mar 1999 | - | $7.78 M(+21.7%) | $25.75 M(+17.9%) |
| Dec 1998 | $21.80 M(+34.1%) | $6.39 M(+30.5%) | $21.84 M(+7.9%) |
| Sept 1998 | - | $4.90 M(-26.6%) | $20.23 M(+3.0%) |
| June 1998 | - | $6.68 M(+72.8%) | $19.64 M(+16.0%) |
| Mar 1998 | - | $3.87 M(-19.3%) | $16.94 M(+4.2%) |
| Dec 1997 | $16.25 M(+135.5%) | $4.79 M(+11.2%) | $16.25 M(+19.0%) |
| Sept 1997 | - | $4.31 M(+8.5%) | $13.66 M(+22.5%) |
| June 1997 | - | $3.97 M(+25.1%) | $11.15 M(+30.0%) |
| Mar 1997 | - | $3.18 M(+44.4%) | $8.58 M(+24.3%) |
| Dec 1996 | $6.90 M(+102.9%) | $2.20 M(+22.2%) | $6.90 M(+25.5%) |
| Sept 1996 | - | $1.80 M(+28.6%) | $5.50 M(+17.0%) |
| June 1996 | - | $1.40 M(-6.7%) | $4.70 M(+9.3%) |
| Mar 1996 | - | $1.50 M(+87.5%) | $4.30 M(+26.5%) |
| Dec 1995 | $3.40 M(+100.0%) | $800.00 K(-20.0%) | $3.40 M(+9.7%) |
| Sept 1995 | - | $1.00 M(0.0%) | $3.10 M(+14.8%) |
| June 1995 | - | $1.00 M(+66.7%) | $2.70 M(+35.0%) |
| Mar 1995 | - | $600.00 K(+20.0%) | $2.00 M(+11.1%) |
| Dec 1994 | $1.70 M | $500.00 K(-16.7%) | $1.80 M(+38.5%) |
| Sept 1994 | - | $600.00 K(+100.0%) | $1.30 M(+85.7%) |
| June 1994 | - | $300.00 K(-25.0%) | $700.00 K(+75.0%) |
| Mar 1994 | - | $400.00 K | $400.00 K |
FAQ
- What is Nektar Therapeutics annual revenue?
- What is the all time high annual revenue for Nektar Therapeutics?
- What is Nektar Therapeutics annual revenue year-on-year change?
- What is Nektar Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Nektar Therapeutics?
- What is Nektar Therapeutics quarterly revenue year-on-year change?
- What is Nektar Therapeutics TTM revenue?
- What is the all time high TTM revenue for Nektar Therapeutics?
- What is Nektar Therapeutics TTM revenue year-on-year change?
What is Nektar Therapeutics annual revenue?
The current annual revenue of NKTR is $90.12 M
What is the all time high annual revenue for Nektar Therapeutics?
Nektar Therapeutics all-time high annual revenue is $1.19 B
What is Nektar Therapeutics annual revenue year-on-year change?
Over the past year, NKTR annual revenue has changed by -$1.93 M (-2.10%)
What is Nektar Therapeutics quarterly revenue?
The current quarterly revenue of NKTR is $24.12 M
What is the all time high quarterly revenue for Nektar Therapeutics?
Nektar Therapeutics all-time high quarterly revenue is $1.09 B
What is Nektar Therapeutics quarterly revenue year-on-year change?
Over the past year, NKTR quarterly revenue has changed by -$20.00 K (-0.08%)
What is Nektar Therapeutics TTM revenue?
The current TTM revenue of NKTR is $93.14 M
What is the all time high TTM revenue for Nektar Therapeutics?
Nektar Therapeutics all-time high TTM revenue is $1.37 B
What is Nektar Therapeutics TTM revenue year-on-year change?
Over the past year, NKTR TTM revenue has changed by +$4.88 M (+5.53%)